Contrast agents in ultrasound

Ultrasound Quarterly

Volumn 13, Issue 3, 1995, Pages 121-138

  Needleman, Laurence ^a   Forsberg, Flemming ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Arteries; Blood flow; Doppler; Microbubbles; Ultrasound; Ultrasound contrast agents

Indexed keywords

ADIPIODONE ETHYL ESTER; ALBUNEX; CONTRAST MEDIUM; ECHOVIST; PERFLUOROOCTYL BROMIDE; SHU 508;

ANGIOGRAPHY; ARTERY OCCLUSION; ARTICLE; ARTIFACT; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; ECHOCARDIOGRAPHY; ECHOENCEPHALOGRAPHY; ECHOGRAPHY; GRAY SCALE ECHOGRAPHY; HEART ATRIUM SEPTUM DEFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ONCOLOGY; PRIORITY JOURNAL; TUMOR VASCULARIZATION; VEIN THROMBOSIS;

EID: 0029556001     PISSN: 08948771     EISSN: 15360253     Source Type: Journal    
DOI: 10.1097/00013644-199509000-00001     Document Type: Article

References (96)

1. Anderson AL, Hampton LD. Acoustics of gas-bearing sediments: I Background. J of Acoust Soc Am 1980;67:1865-89.
2. Andre MP, Steinbach G, Mattrey RF. Enhancement of the echogenicity of flowing blood by the contrast agent perflubron. Invest Radiol 1993;28:502-6.
3. Balen F, Allen C, Lees W. Ultrasound contrast agents. Clin Radiol 1994;49:77-82.
4. Barnhart J, Harada M, Lyle L, Saravis C. Immunologic reactions of human recipients to repeated exposures to Albunex microspheres. Invest Radiol 1991; 26:S192-3.
5. Barnhart J, Levene H, Villapando E, et al. Characteristics of Albunex: air-filled albumin microspheres for echocardiography contrast enhancement. Invest Radiol 1990;25(suppl 1): S162-4.
6. Bêcher H, Schlief R, Luderitz B. Improved sensitivity of color Doppler by SHU 454. Am J Cardiol 1989:64:374-77.
7. Behan M, O’Connell D, Mattrey R, Carney D. Perfluorooc-tylbromide as a contrast agent for CT and sonography: preliminary clinical results. Am J Radiol 1993; 160:399-405.
8. Bleeker H, Shun K, Barnhart J. Ultrasonic characterization of Albunex, a new contrast agent. J Acoust Soc Am 1990:78: 1792-7.
9. Bleeker H, Shung K, Barnhart J. On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion. J Ultrasound Med 1990; 9:461-71.
10. Bogdahn U, Frohlich T, Becker G, et al. Vascularization of primary central nervous system tumors: detection with contrast-enhanced transcranial color-coded real-time sonography, Radiology 1994; 192:141-8.
11. Burns P, Hilpert P, Goldberg B. Intravenous contrast agent for ultrasound Doppler: in vivo measurement of small tumor vessel dose-response. Proc IEEE Eng Med Biol Soc 1990; 12:3224.
12. Burns P, Powers J, Simpson D. et al. Harmonic power mode Doppler using microbubble contrast agents: an improved method for small vessel flow imaging. Proc IEEE Ultrasonics Symp 1994:1547-50.
13. Burns PN, Powers JE, Fritzsch T et al. Harmonic imaging: new imaging and Doppler method for contrast-enhanced ultrasound. Radiology 1992; 182:142.
14. Burns PN, Powers JE, Hope-Simpson D, Uhlendorf V, Fritzsch T. Power Doppler imaging combined with contrast-enhancing harmonic Doppler: a new method for small-vessel imaging [Abstract]. Radiology 1994; 193:366.
15. Chang P, Shung K. Second harmonic imaging and harmonic Doppler measurements with Albunex. Proc IEEE Ultrasonics Symp 1994:1551-4.
16. Coley B, Mattrey R, Roberts A, Keane S. Potential role of PFOB enhanced sonography of the kidney. II. Detection of partial infarction. Kidney Int 1991;39:740-5.
17. Coley B, Trambert M, Mattrey R. Perfluorocarbon-enhanced sonography: value in detecting acute venous thrombosis in rabbits. Am J Radiol 1994; 163:961-4.
18. Cosgrove DO. Levovist in breast and prostate cancer. Proceedings of symposium on ultrasound contrast agents. The leading edge in diagnostic ultrasound. Atlantic City, 1995:47-9.
19. Cosgrove DO. TRUS with contrast agents in carcinoma of the prostate. In: Murphy G, Khoury S, Chatelain C, Denis L, eds. Proceedings of 4th International Symposium on Recent Advances in Urological Cancer. Paris: Scientific Communications International, 1995:131.
20. Crouse L, Cheirif J, Hanly D, et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of a phase III Albunex multicenter trial. J AM Coll Cardiol 1993;22: 1494-500.
21. D’Arrigo J, Ho S, Simon R. Detection of experimental rat liver tumors by contrast-assisted ultrasonography. Invest Radiol 1993;28:218-22.
22. de Jong N, Cornet R, Lancee C. Higher harmonics of vibrating gas-filled microspheres. Part one: simulations. Ultrasonics 1994;32:447-53.
23. de Jong N, Cornet R, Lancee C. Higher harmonics of vibrating gas-filled microspheres. Part two: measurements. Ultrasonics 1994:32:455-9.
24. de Jong N, Hoff L, Skotland T, Bom N. Absorption and scatter of encapsulated gas filled microspheres: theroretical considerations and some measurements. Ultrasonics. 1992;30:95-103.
25. de Jong N, Ten Cate FJ, Lancee CT, Roelandt JRTC, Bom N. Principles and recent developments in ultrasound contrast agents. Ultrasonics 1991;29:324-30.
26. Deichert U, Schlief R, van de Sandt M, Juhnke I. Transvaginal hysterosalpingo contrast sonography compared with conventional tubal diagnostics. Human Reprod 1989;4:418-24.
27. Dittrich J, Kuvelas T, Bales G, McFerran B, Hunt R, Greener Y. Myocardial contrast echocardiography using a new intravenously administered agent: relationship between perfusion defect and wall motion abnormality in experimental coronary artery occlusion [Abstract]. J Am Soi Echocardiogr 1994;7:S31.
28. Duda VF. Rode G. Schlief R. Echocontrast agent enhanced color flow imaging of the breast. Ultrasound Ohstet Gynecol 1993;3:191-4.
29. El Mouaaouy A, Becker HD, Schlief R, Kuhlo C, Portas C. Rat liver model for testing intraoperative echo contrast sonography. Surg Endosc 1990;4:114-7.
30. Fan P. Czuwala P, Nanda N, Rosenthal S, Yoganathan A. Comparison of vaious agents in contrast enhancement of color Doppler flow images: an in vitro study. Ultrasound Med Biol 1993:19:45-57.
31. Forsberg F, Liu JB, Burns PN, Merton DA, Goldberg BB. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 1994;13:357-65.
32. Forsberg F, Liu JB, Merton DA, Goldberg BB. Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med 1995; 14:949-57.
33. Forsberg F. Liu JB, Merton DA, Rawool NM, Goldberg BB. In vivo evaluation of a new ultrasound contrast agent. Proc IEEE Ultrasound Symp 1994:1555-8.
34. Forsberg F, Newhouse VL, Liu JB, Merton DA, Dickerson KS, Halpern EJ. In-vivo application of contrast-enhanced harmonic imaging [Abstract]. Radiology 1993; 189:285.
35. Frush DP, Babcock DS, White KS, Barr LL. Quantification of intravenous contrast-enhanced Doppler power spectrum in the rabbit carotid artery. Ultrasound Med Biol 1995;21:41-7.
36. Goldberg B, Liu J, Forsberg F. Ultrasound contrast agents: a review. Ultrasound Med Biol 1994;20:319-33.
37. Goldberg BB, Forsberg F, Fritzsch T, Liu JB, Merton DA. Induced acoustic emission as a contrast mechanism for detection of hepatic abnormalities. J Ultrasound Med 1995; 14:S7.
38. Goldberg BB. Hilpert PL, Burns PN, Liu JB. Hepatic tumors: Signal enhancement of Doppler US after intravenous injection of a contrast agent. Radiology 1990; 177:713-7.
39. Goldberg BB, Liu JB, Burns PN, Merton DA, Forsberg F. Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med 1993; 12:463-70.
40. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968;3:356-66.
41. Gramiak R, Shah PM, Kramer DH. Ultrasound cardiography: Contrast studies in anatomy and function. Radiology 1969;92: 939.
42. Hilpert PL, Mattrey RF, Mitten RM, Peterson T. IV injection of air-filled human albumin microspheres to enhance arterial Doppler signal: A preliminary study in rabbits. Am J Roentgenol 1989; 153:613-6.
43. Jauss M, Kaps M, Keberle M, Haberbosch W, Dorndorf W. A comparison of transesophageal echocardiography and transcranial Doppler sonography with contrast medium for detection of patent foramen ovale. Stroke 1994;25:1265-7.
44. Job FP, Ringelstein EB, Grafen Y, et al. Comparison of transcranial Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol 1994; 74:381-4.
45. Kedar RP. Cosgrove DO, McCready VR, Bamber JC. Micro-bubble Doppler angiography of breast masses: dynamic and morphological features. Radiology 1993; 189:154.
46. Klotzsch C, Janfien G, Berlit P. Transesophageal echocardiography and contrast-TCD in the detection of a patent foramen ovale: experiences in 111 patients. Neurology 1994;44:1603-6.
47. Kudo M, Tomita S, Tochio H. Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial C02 microbubbles. Radiology 1992; 182:155-60.
48. Kudo M, Tomita S, Tochio J. Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. Am J Roentgenol 1992; 158:65-74.
49. Matsuda Y, Yabuuchi T. Hepatic tumors: US contrast enhancement with CO2 microbubbles. Radiology 1986; 161:7015.
50. Mattrey R. Perfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging. Am J Roentgenol 1989; 152: 247-52.
51. Mattrey R, Leopold G, vanSonnenberg E, Gosink B, Scheible F, Long D. Perfluorochemicals as liver-and spleen-seeking ultrasound contrast agents. J Ultrasound Med 1983; 2:173-6.
52. Mattrey R, Scheible F, Gosink B, Leopold G, Long D, Higgins C. Perfluorocytlbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material. Radiology 1982; 145:75962.
53. Mattrey RF, Wrigley R, Steinbach GC, Schutt EG, Evitts DP. Gas emulsions as ultrasound contrast agents: preliminary results in rabbits and dogs. Invest Radiol 1994; 29(suppl 2):S139-41.
54. Morse PM, Ingard KV. Theoretical acoustics. New York: McGraw-Hill, 1968.
55. Needleman L, Goldberg B, Feld R, Merton D, Liu J. Evaluation of arterial disease in humans using an ultrasound contrast agent [Abstract]. J Ultrasound Med 1994; 13:S48.
56. Needleman L, Merton DA, Liu JB, Goldberg BB. Evaluation of the safety and contrast enhancement of intravenous EchoGen™ in normal adult males. J Ultrasound Med 1995; 14:S55.
57. Needleman L, Nack TL, Feld RI, Goldberg BB. Initial experience with an US contrast agent in upper-extremity venous thrombosis [Abstract]. Radiology 1992; 185:143.
58. Newhouse V, Hoover M, Ash S. The detection of blood impurities using ultrasound Doppler. Ultrasonic Imaging 1980:2: 370-80.
59. Nomura Y, Matsuda Y, Yabuuchi I, Nishioka M, Tarui S. Hepatocellular carcinoma in adenomatous hyperplasia: detection with contrast-enhanced US with carbon dioxide microbubbles. Radiology 1993; 187:353-6.
60. Ophir J, Parker K. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989; 15:319-33.
61. Otis S, Rush M, Boyajian R. Contrast-enhanced transcranial imaging. Results of an American phase-two study. Stroke 1995;26:203-9.
62. Parker K, Baggs R, Lerner R, Tuthill T, Violante M. Ultrasound contrast for hepatic tumors using IDE particals. Invest Radiol 1990;25:1135-9.
63. Parker K, Tuthill T, Lerner R, Violante M. A particulate contrast agent with potential for ultrasound imaging of liver. Ultrasound Med Biol 1987; 13:555-66.
64. Quay SC. Microbubble-based ultrasound contrast agents: the role of gas selection in microbubble persistence [Abstract]. J Ultrasound Med 1994; 13:S9.
65. Quay SC. Ultrasound contrast agent development: phase shift colloids [Abstract]. J Ultrasound Med 1994; 13:S9.
66. Ries F, Hönisch C, Lanbertz M, Schlief R. A transpulmonary contrast medium enhances the transcranial Doppler signal in humans. Stroke 1993;24:1903-9.
67. Rosenkranz K, Zendel W, Langer R, et al. Contrast-enhanced trascranial Doppler US with a new transpulmonary echo contrast agent based on saccharide microparticles. Radiology 1993;187:439-43.
68. Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler US: a potentially useful alternative to mean-frequency-based color Doppler US. Radiology 1994; 190:853-6.
69. Schlief R. Echovist®; physico-pharmacological properties. Results of clinical studies and possible fields of use of a novel ultrasound contrast medium. In: HP G, ed. Jahrbuch der Radiologie. Münster, Germany: Regensberg and Biermann, 1988: 163-170.
70. Schlief R. Ultrasound contrast agents. Curr Sei 1991; 3:198-207.
71. Schlief R. Galactose based echo enhancing agents. Proceedings of symposium on ultrasound contrast agents. The leading edge in diagnostic ultrasound. Atlantic City, 1995:25-6.
72. Schlief R, Deichen U. Hysterosalpingo-contrast sonography of the uterus and fallopian tubes: results of a clinical trial of a new contrast medium in 120 patients. Radiology 1991; 178:213-5.
73. Schlief R, Schurmann R, Balzer T, et al. Saccharide-based contrast agents and their application in vascular Doppler ultrasound. Adv Echo Contrast 1994;3:60-76.
74. Schlief R, Schurmann R, Niendorf H. Blood-pool enhancement with SHU 508 A: results of phase II clinical trials. Invest Radiol 1991:26(suppl 1):S188-9.
75. Schlief R, Staks T, Mahler M, Rufer M, Fritzsch T, Seifert W. Successful opacification of the left heart chambers on echocari-ographic examination after intravenous injection of a new saccharide based contrast agent. Echocardiography 1990; 7:61-4.
76. Schneider M. Broillet A, Bussat P, Ventrone R. The use of polymeric microballoons as ultrasound contrast agents for liver imaging. Invest Radiol 1994; 29(suppl 2):S149-51.
77. Schneider M, Bussat P, Barrau M, et al. A new ultrasound contrast agent based on biodegradable polymeric microballoons. Invest Radiol 1991; 26:S190-1.
78. Schrope B, Newhouse VL, Uhlendorf V. Simulated capillary blood flow measurement using a nonlinear ultrasonic contrast agent. Ultrasonic Imaging 1992;14:134-58.
79. Schrope BA, Newhouse VL. Second harmonic ultrasonic blood perfusion measurement. Ultrasound Med Biol 1993; 19:567-79.
80. Schwarz K, Becher H, Schimpfky C, Vorwerk D, Bogdahn U, Schlief R. Doppler enhancement with SH U 508A in multiple vascular regions. Radiology 1994; 193:195-201.
81. Schwarz K, Bezante G, Chen X, Schlief R. Quantitative echo contrast concentration measurement by Doppler sonography. Ultrasound Med Biol 1993; 19:289-97.
82. Shmulewitz A. Ultrasonic multifeature maps of liver based on an amplitude loss technique and a conventional B-scan. IEEE Trans Biomed Eng 1992;39:445-9.
83. Simon R, Ho S, Perkins C, D’Arrigo J. Quantitative assessment of tumor enhancement by ultrastable lipid-coated microbubbles as a sonographic contrast agent. Invest Radiol 1992; 27:2934.
84. Sitzer M, Furst G, Siebler M, Steinmetz H. Usefulness of an intravenous contrast medium in the characterization of high grade internal carotid stenosis with color Doppler-assisted duplex imaging. Stroke 1994;25:385-7.
85. Takada T, Yasuda H, Uchiyama K, Hasegawa H, Shikata J. Contrast-enhanced intraoperative ultrasonography of small hepatocellular carcinomas. Surgery 1990; 107:528-32.
86. Takase K, Takahashi S, Tazawa S, Terasawa Y, Sakamoto K. Renal cell carcinoma associated with chronic renal failure: evaluation with sonographic angiography. Radiology 1994; 192:787-92.
87. Tanaka S, Kitamra T, Yoshioka F, et al. Effectiveness of galac-tose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma. Ultrasound Med Biol 1995; 21:157-60.
88. Tickner E, Rasor N. An instrument for the noninvasive assessment of pulmonary hypertension. Adv Bioeng ASNE 1978: 101-3.
89. Tuthill T, Baggs R, Violante M, Parker K. Ultrasound properties of liver with and without particulate contrast agents. Ultrasound Med Biol 1991; 17:231-7.
90. Uhlendorf V, Hoffmann C. Nonlinear acoustical response of coated microbubbles in diagnostic ultrasound. Prox IEEE Ultrason Symp 1994:1559-62.
91. Unger E, Shen D, Fritz T, et al. Gas-filled lipid bilayersas ultrasound contrast agents. Invest Radiol 1994;29(suppl 2): S134-6.
92. Unger EC, Lund PJ, Shen D-K, Fritz TA, Yellowhair D, New TE. Nitrogen-filled liposomes as a vascular US contrast agent: preliminary evaluation. Radiology 1992; 185:453-6.
93. Violante M. Baggs R, Tuthill T. Dentinger P, Parker K. Particle-stabilized bubbles for enhanced organ ultrasound imaging. Invest Radiol 1991; 26:S194-7.
94. Vorwerk D, Gehl H, Nelles A, Gunther R. Dynamic contrast medium-aided ultrasound venacavography in patients with caval filters. Ultraschall Med 1990; 11:146-9.
95. Walday P, Ostensen J, Tolleshaug H, Holtz E. Albunex-a new ultrasound contrast agent; effects on hemodynamics, contrast, and biodistribution in different species. Invest Radiol 1994; 29(suppl 2):S142-4.
96. Wible J, Adams M, Sherwin P, et al. Noncardiac applications of albunex. Invest Radiol 1994;29(suppl 2):S145-8.